Semler Scientific, Inc. (OTCMKTS:SMLR)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $136.24 and last traded at $133.00, with a volume of 42949 shares traded. The stock had previously closed at $129.12.
A number of research firms have commented on SMLR. TheStreet raised shares of Semler Scientific from a “d-” rating to an “a-” rating in a research report on Tuesday, September 28th. B. Riley reaffirmed a “buy” rating and issued a $151.00 target price on shares of Semler Scientific in a research report on Wednesday, August 4th. Zacks Investment Research cut shares of Semler Scientific from a “buy” rating to a “hold” rating in a research note on Thursday, October 7th. Lake Street Capital lifted their price target on shares of Semler Scientific from $150.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, September 28th. Finally, Colliers Securities reiterated an “average” rating and set a $151.00 price target on shares of Semler Scientific in a research note on Tuesday, September 28th. Two equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $157.75.
The company’s 50 day moving average price is $114.62 and its two-hundred day moving average price is $112.95. The firm has a market cap of $922.93 million, a PE ratio of 50.61, a PEG ratio of 1.52 and a beta of 0.85.
In related news, CEO Douglas Murphy-Chutorian sold 1,250 shares of Semler Scientific stock in a transaction on Monday, October 11th. The shares were sold at an average price of $129.01, for a total transaction of $161,262.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 13.60% of the stock is currently owned by insiders.
About Semler Scientific (OTCMKTS:SMLR)
Semler Scientific, Inc engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluate its customers patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests.
See Also: What is Depreciation?
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.